N-(3'-Fluoropropyl-)-3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)nortropane
From Wikipedia, the free encyclopedia
|
N-(3'-Fluoropropyl-)-3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)nortropane
|
|
| Systematic (IUPAC) name | |
| N-(3'-Fluoropropyl)-3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)nortropane | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C25H26ClFN2O |
| Mol. mass | 424.94 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
N-(3'-Fluoropropyl-)-3β-(4'-chlorophenyl)-2β-(3'-phenylisoxazol-5'-yl)nortropane (FP-β-CPPIT) is a cocaine analogue. [1]
[edit] References
- ^ Evaluation of Three Cocaine Analogues as PET tracers for the Dopamine Transporter and Synthetic Approaches to [F-18-DFMO]. Retrieved on 2008-01-11.

